• Home
  • About
    • Psychedelic For Healthy People
    • Psilocybin (Magic Mushrooms)
    • Ayahuasca (Chacruna – Kaapi – Yajé)
    • MDMA (MDA – Sassafras)
    • Peyote Mescaline (Huachuma)
    • Kambo – Amazonian Frog
    • 5-MeO-DMT (Toad Medicine)
    • Rapé And Sacred Tobacco
    • Iboga (Ibogaine)
    • LSD (Lysergic Acid Diethylamide)
    • Cannabis (Marijuana)
    • Ketamine
    • Psychedelic Integration
    • Psychedelics Advocates
    • Frequently Asked Questions
    • Mental Health Symptoms
    • Substances Test Kits
    • Manifesto
  • Treatments
    • Latest Psychedelic Research
    • Addiction
    • Alcoholism
    • Anxiety
    • Bipolar Disorder
    • Cancer
    • Cluster Headaches
    • Depression
    • End Of Life
    • OCD
    • Neuropathy
    • Pain
    • Parkinson’s Disease
    • PTSD
    • Smoking
    • Help Treat Mental Illness
  • Microdosing
    • What is Microdosing?
    • Microdosing Magic Mushrooms
    • Microdosing LSD
    • Microdosing MDMA
    • Microdosing Ayahuasca
    • Microdosing Mescaline
    • Microdosing Cannabis
    • Microdosing Ibogaine
  • Resources
    • Past Events
    • ALL Locations
    • DMT Psychoactive Plants
    • Medical Trials And Research
    • Psychedelic Research
    • EntheoPodcasts
    • In The News
    • Books On Psychedelics
    • Related Videos
    • EntheoResources
    • Terence McKenna
    • What Is Psychedelic Art?
    • Useful Links
    • Movies & Documentaries
    • Michael Pollan
Contact
  • Follow
  • Follow
  • Follow
  • Follow
So You Want to be a Psychedelic Researcher?

So You Want to be a Psychedelic Researcher?

by EmpathiCSubstanceS | Nov 9, 2021 | Iboga, LSD, MDMA Sassafras Molly, Psychotropics, PTSD, San Pedro Mescaline

With the current renaissance in psychedelic research, after a forty-year moratorium, undergraduates interested in the topic are increasingly starting to ask: How can I get involved? Unfortunately, psychedelics are still heavily stigmatized, and there is as yet no...
So You Want to be a Psychedelic Researcher?

Why Veterans Need Ayahuasca Integration and Access to Plant Medicines

by EmpathiCSubstanceS | Nov 9, 2021 | Alcoholism, Anxiety, Ayahuasca, Bipolar Disorder

Thanks for speaking with us again, Wyly. Can you share more about what Veterans of War does and how it’s structured to serve veterans who are struggling with PTSD? Veterans of War has a unit mentality. I’m trying to recreate a sense of a shared community and a shared...
So You Want to be a Psychedelic Researcher?

How Medical Science Grapples with Psychedelic Plants like Ayahuasca and Ibogaine?

by EmpathiCSubstanceS | Nov 9, 2021 | LSD, Microdosing, Psychotropics

Thank you again for speaking with us, Professor Nutt. What current research and frontiers are you exploring at Imperial College London? Well, I’m very excited about three things. One is that we’ve just finished the first MDMA and alcoholism study—a safety,...
So You Want to be a Psychedelic Researcher?

Why We Hide Our Drug Use, and Why We Shouldn’t

by EmpathiCSubstanceS | Nov 9, 2021 | Anxiety, Bipolar Disorder, Cannabis Marijuana, Chronic Pain

Dr. Carl Hart’s argument that we should de stigmatize, legalize, and regulate all drugs is revolutionary for two main reasons. For one, he is an internationally lauded neuroscientist and neuropsychopharmacologist, and one of the world’s leading experts on drug use,...
So You Want to be a Psychedelic Researcher?

What Happens When Blind People Take Psychedelics?

by EmpathiCSubstanceS | Nov 9, 2021 | Addiction, Alcoholism, Iboga, MDMA Sassafras Molly

Earlier this month, a student from Singapore tripping on shrooms in a Bali hotel jumped five floors to his death. The news recalled an incident from a year ago, when a 23-year old banker at Merrill Lynch had plunged 26 stories after eating some magic mushrooms. These...
« Older Entries
Next Entries »

IMPORTANT NOTICE:

This community is being designed as a secure space. It is not a place to seek, encourage, or participate in the procurement of controlled substances. Do not bring, buy, sell, transfer, or arrive on any illegal substances, or swap information on how to buy them. Attendees and/or members of this community who violate these basic house rules will be removed from the community and will not be allowed to attend future events.

Psychedelic Research

LSD enhances suggestibility in healthy volunteers

Aug 16, 2022

Volunteers gave significantly higher ratings for the CIS (p = 0.018), but not the MIT (p = 0.11), after LSD than placebo. The magnitude of suggestibility enhancement under LSD was positively correlated with trait conscientiousness measured at baseline (p = 0.0005)....

Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor

Aug 16, 2022

LSD reduced associative, but concurrently increased sensory-somatomotor brain-wide and thalamic connectivity. Ketanserin fully blocked the subjective and neural LSD effects. Whole-brain spatial patterns of LSD effects matched 5-HT2A receptor cortical gene expression...

N,N-dimethyltryptamine and the pineal gland: Separating fact from myth.

Aug 16, 2022

It is clear that very minute concentrations of N,Ndimethyltryptamine have been detected in the brain, but they are not sufficient to produce psychoactive effects. Alternative explanations are presented to explain how stress and near death can produce altered states of...

Psychedelic Medicine

Remembering Dr. Jordi Riba, Ayahuasca Research Pioneer (1968–2020)

Nov 9, 2020

On August 14, 2020, the world bid farewell to scientific pioneer, Dr. Jordi Riba. The untimely death of the Catalan ayahuasca researcher has come as a harsh blow to the close-knit ayahuasca community the world over. Riba was undoubtedly one of the most prolific...

Compass Pathways’ Leads the Way as the First Psychedelics Company To IPO on the Nasdaq FN Media Group Presents Microsmallcap.com Market Commentary

Nov 8, 2020

NEW YORK, Sept. 24, 2020 /PRNewswire/ -- Last year may have been all about cannabis, but it's clear that 2020 and beyond belongs to the psychedelic medicine market. Ever since Johnson & Johnson's (NYSE:JNJ) ketamine-derived medicine, Spravato, received the first...

UC Berkeley launches new center for psychedelic science and education

Nov 8, 2020

Fifty years after political and cultural winds slammed shut the doors on psychedelic research, UC Berkeley is making up for lost time by launching the campus’s first center for psychedelic science and public education. With $1.25 million in seed funding from an...

Colorado’s Nowak Society Launches Public Education Campaign on Psychedelics

Nov 8, 2020

On May 7, 2019, the city of Denver made headlines for becoming the first U.S. city to effectively decriminalize psilocybin mushrooms through its passing of Initiated Ordinance 301 (I-301). In the months that followed, Oakland and Santa Cruz followed suit,...

Company Seeks to Patent Psilocybin for Weight Loss

Nov 8, 2020

Psilocybin has been fast-tracked by the FDA to become a prescription medication in psychedelic-assisted therapy for depression, but now we’re seeing investors line up to support a new indication for the synthetic compound that’s been made famous—in its organic form—by...

© 2025| All Rights Reserved, EntheoMedicine Community
  • Follow
  • Follow
  • Follow
  • Follow